HEADER OXIDOREDUCTASE 28-FEB-01 1I5R TITLE TYPE 1 17-BETA HYDROXYSTEROID DEHYDROGENASE EM1745 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYPE 1 17 BETA-HYDROXYSTEROID DEHYDROGENASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ESTRADIOL 17 BETA-DEHYDROGENASE 1, PLACENTAL 17-BETA- COMPND 5 HYDROXYSTEROID DEHYDROGENASE; COMPND 6 EC: 1.1.1.62; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS DEHYDROGENASE, 17BETA-HYDROXYSTEROID, HYBRID, INHIBITOR, KEYWDS 2 OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR W.QIU,R.L.CAMPBELL,P.BOIVIN,D.POIRIER,S.-X.LIN REVDAT 4 09-AUG-23 1I5R 1 REMARK REVDAT 3 13-JUL-11 1I5R 1 VERSN REVDAT 2 24-FEB-09 1I5R 1 VERSN REVDAT 1 11-MAR-03 1I5R 0 JRNL AUTH W.QIU,R.L.CAMPBELL,A.GANGLOFF,P.DUPUIS,R.P.BOIVIN, JRNL AUTH 2 M.R.TREMBLAY,D.POIRIER,S.X.LIN JRNL TITL A CONCERTED, RATIONAL DESIGN OF TYPE 1 17BETA-HYDROXYSTEROID JRNL TITL 2 DEHYDROGENASE INHIBITORS: ESTRADIOL-ADENOSINE HYBRIDS WITH JRNL TITL 3 HIGH AFFINITY JRNL REF FASEB J. V. 16 1829 2002 JRNL REFN ISSN 0892-6638 JRNL PMID 12223444 REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 36941 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1847 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2181 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 67 REMARK 3 SOLVENT ATOMS : 231 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.007 ; NULL REMARK 3 ANGLE DISTANCE (A) : 0.027 ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.465 ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.209 ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1I5R COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-MAR-01. REMARK 100 THE DEPOSITION ID IS D_1000012938. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-APR-99 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X8C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.009 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : PARABOLIC COLLIMATING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38831 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 200 DATA REDUNDANCY : 2.400 REMARK 200 R MERGE (I) : 0.03100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 26.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : 0.10900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 6.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 1BHS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG3500, GLYCEROL, SODIUM CHLORIDE, REMARK 280 BETA-OCTYL GLUCOSIDE, DITHIOTHREITOL, PH 7.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 292K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 59.63600 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 21.35300 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 59.63600 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 21.35300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9240 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 20390 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -52.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 286 REMARK 465 VAL A 287 REMARK 465 PRO A 288 REMARK 465 ALA A 289 REMARK 465 LYS A 290 REMARK 465 ALA A 291 REMARK 465 GLU A 292 REMARK 465 ALA A 293 REMARK 465 GLY A 294 REMARK 465 ALA A 295 REMARK 465 GLU A 296 REMARK 465 ALA A 297 REMARK 465 GLY A 298 REMARK 465 GLY A 299 REMARK 465 GLY A 300 REMARK 465 ALA A 301 REMARK 465 GLY A 302 REMARK 465 PRO A 303 REMARK 465 GLY A 304 REMARK 465 ALA A 305 REMARK 465 GLU A 306 REMARK 465 ASP A 307 REMARK 465 GLU A 308 REMARK 465 ALA A 309 REMARK 465 GLY A 310 REMARK 465 ARG A 311 REMARK 465 SER A 312 REMARK 465 ALA A 313 REMARK 465 VAL A 314 REMARK 465 GLY A 315 REMARK 465 ASP A 316 REMARK 465 PRO A 317 REMARK 465 GLU A 318 REMARK 465 LEU A 319 REMARK 465 GLY A 320 REMARK 465 ASP A 321 REMARK 465 PRO A 322 REMARK 465 PRO A 323 REMARK 465 ALA A 324 REMARK 465 ALA A 325 REMARK 465 PRO A 326 REMARK 465 GLN A 327 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 TYR A 33 CB - CG - CD2 ANGL. DEV. = -4.5 DEGREES REMARK 500 ARG A 132 NE - CZ - NH2 ANGL. DEV. = 4.5 DEGREES REMARK 500 ARG A 252 CG - CD - NE ANGL. DEV. = -12.8 DEGREES REMARK 500 ARG A 252 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 95 113.25 -160.69 REMARK 500 VAL A 115 -61.85 -99.60 REMARK 500 MET A 193 -141.76 20.53 REMARK 500 GLU A 194 -20.99 70.97 REMARK 500 LEU A 197 -73.94 -36.87 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HYC A 328 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 403 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1IOL RELATED DB: PDB DBREF 1I5R A 1 327 UNP P14061 DHB1_HUMAN 1 327 SEQRES 1 A 327 ALA ARG THR VAL VAL LEU ILE THR GLY CYS SER SER GLY SEQRES 2 A 327 ILE GLY LEU HIS LEU ALA VAL ARG LEU ALA SER ASP PRO SEQRES 3 A 327 SER GLN SER PHE LYS VAL TYR ALA THR LEU ARG ASP LEU SEQRES 4 A 327 LYS THR GLN GLY ARG LEU TRP GLU ALA ALA ARG ALA LEU SEQRES 5 A 327 ALA CYS PRO PRO GLY SER LEU GLU THR LEU GLN LEU ASP SEQRES 6 A 327 VAL ARG ASP SER LYS SER VAL ALA ALA ALA ARG GLU ARG SEQRES 7 A 327 VAL THR GLU GLY ARG VAL ASP VAL LEU VAL CYS ASN ALA SEQRES 8 A 327 GLY LEU GLY LEU LEU GLY PRO LEU GLU ALA LEU GLY GLU SEQRES 9 A 327 ASP ALA VAL ALA SER VAL LEU ASP VAL ASN VAL VAL GLY SEQRES 10 A 327 THR VAL ARG MET LEU GLN ALA PHE LEU PRO ASP MET LYS SEQRES 11 A 327 ARG ARG GLY SER GLY ARG VAL LEU VAL THR GLY SER VAL SEQRES 12 A 327 GLY GLY LEU MET GLY LEU PRO PHE ASN ASP VAL TYR CYS SEQRES 13 A 327 ALA SER LYS PHE ALA LEU GLU GLY LEU CYS GLU SER LEU SEQRES 14 A 327 ALA VAL LEU LEU LEU PRO PHE GLY VAL HIS LEU SER LEU SEQRES 15 A 327 ILE GLU CYS GLY PRO VAL HIS THR ALA PHE MET GLU LYS SEQRES 16 A 327 VAL LEU GLY SER PRO GLU GLU VAL LEU ASP ARG THR ASP SEQRES 17 A 327 ILE HIS THR PHE HIS ARG PHE TYR GLN TYR LEU ALA HIS SEQRES 18 A 327 SER LYS GLN VAL PHE ARG GLU ALA ALA GLN ASN PRO GLU SEQRES 19 A 327 GLU VAL ALA GLU VAL PHE LEU THR ALA LEU ARG ALA PRO SEQRES 20 A 327 LYS PRO THR LEU ARG TYR PHE THR THR GLU ARG PHE LEU SEQRES 21 A 327 PRO LEU LEU ARG MET ARG LEU ASP ASP PRO SER GLY SER SEQRES 22 A 327 ASN TYR VAL THR ALA MET HIS ARG GLU VAL PHE GLY ASP SEQRES 23 A 327 VAL PRO ALA LYS ALA GLU ALA GLY ALA GLU ALA GLY GLY SEQRES 24 A 327 GLY ALA GLY PRO GLY ALA GLU ASP GLU ALA GLY ARG SER SEQRES 25 A 327 ALA VAL GLY ASP PRO GLU LEU GLY ASP PRO PRO ALA ALA SEQRES 26 A 327 PRO GLN HET HYC A 328 49 HET GOL A 401 6 HET GOL A 402 6 HET GOL A 403 6 HETNAM HYC O5'-[9-(3,17B-DIHYDROXY-1,3,5(10)-ESTRATRIEN-16B-YL)- HETNAM 2 HYC NONANOYL]ADENOSINE HETNAM GOL GLYCEROL HETSYN HYC EM-1745 HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 HYC C37 H51 N5 O7 FORMUL 3 GOL 3(C3 H8 O3) FORMUL 6 HOH *231(H2 O) HELIX 1 1 SER A 12 SER A 24 1 13 HELIX 2 2 ASP A 38 THR A 41 5 4 HELIX 3 3 GLN A 42 LEU A 52 1 11 HELIX 4 4 ASP A 68 ARG A 78 1 11 HELIX 5 5 PRO A 98 LEU A 102 5 5 HELIX 6 6 GLY A 103 VAL A 115 1 13 HELIX 7 7 VAL A 115 GLY A 133 1 19 HELIX 8 8 GLY A 144 LEU A 146 5 3 HELIX 9 9 ASN A 152 LEU A 174 1 23 HELIX 10 10 SER A 199 ARG A 206 1 8 HELIX 11 11 ASP A 208 ALA A 230 1 23 HELIX 12 12 ASN A 232 ALA A 246 1 15 HELIX 13 13 PHE A 259 ASP A 269 1 11 HELIX 14 14 GLY A 272 GLY A 285 1 14 SHEET 1 A 7 LEU A 59 GLN A 63 0 SHEET 2 A 7 PHE A 30 LEU A 36 1 O VAL A 32 N GLU A 60 SHEET 3 A 7 THR A 3 ILE A 7 1 O THR A 3 N LYS A 31 SHEET 4 A 7 VAL A 86 CYS A 89 1 O VAL A 86 N LEU A 6 SHEET 5 A 7 GLY A 135 SER A 142 1 O ARG A 136 N LEU A 87 SHEET 6 A 7 VAL A 178 CYS A 185 1 O HIS A 179 N VAL A 137 SHEET 7 A 7 ARG A 252 PHE A 254 1 O TYR A 253 N GLU A 184 SITE 1 AC1 31 GLY A 9 SER A 11 SER A 12 ARG A 37 SITE 2 AC1 31 LEU A 64 ASP A 65 VAL A 66 ARG A 67 SITE 3 AC1 31 ASN A 90 ALA A 91 GLY A 92 LEU A 93 SITE 4 AC1 31 GLY A 94 SER A 142 MET A 147 LEU A 149 SITE 5 AC1 31 TYR A 155 PHE A 192 MET A 193 TYR A 218 SITE 6 AC1 31 HIS A 221 SER A 222 PHE A 226 PHE A 259 SITE 7 AC1 31 MET A 279 GLU A 282 GOL A 401 HOH A 410 SITE 8 AC1 31 HOH A 430 HOH A 489 HOH A 557 SITE 1 AC2 8 GLY A 186 PRO A 187 VAL A 188 PHE A 192 SITE 2 AC2 8 PHE A 226 HYC A 328 HOH A 438 HOH A 621 SITE 1 AC3 9 LEU A 146 ARG A 252 PHE A 254 ARG A 266 SITE 2 AC3 9 ASP A 269 PRO A 270 GOL A 403 HOH A 416 SITE 3 AC3 9 HOH A 452 SITE 1 AC4 7 GLY A 145 LEU A 146 PHE A 160 GLU A 163 SITE 2 AC4 7 ARG A 266 GOL A 402 HOH A 416 CRYST1 119.272 42.706 58.732 90.00 99.16 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008384 0.000000 0.001352 0.00000 SCALE2 0.000000 0.023416 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017246 0.00000